The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

NCT03120936 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

158

Enrollment

OTHER

Sponsor class

Conditions

Transgender Persons
Pre-Exposure Prophylaxis

Interventions

DRUG: Emtricitabine / Tenofovir Disoproxil Oral Tablet
BEHAVIORAL: PrEP support

Sponsor

Public Health Foundation Enterprises, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]